A Retrospective Analysis of Outcomes in Patients with Acute Coronary Syndrome, Including Mortality Rates and Readmission Rates
International Journal of Current Pharmaceutical Review and Research · 30.04.2026 · 18 (04)
DOI: 10.25258/ijcpr.18.4.141 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.04.2026. Verfasst von Ravikant Ravikant und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Acute Coronary Syndrome (ACS) is one of the leading causes of morbidity and mortality in both developed and developing countries. With the mortality and readmission rates being critical indicators of the quality of cardiac care, an early assessment of such rates is of greatest importance so these areas can be further improved.
Methods
A retrospective observational study of 112 adult patients aged 18 years who presented with a diagnosis of ACS, ST-Segment Elevation Myocardial Infarction (STEMI), Non-ST-Segment Elevation Myocardial Infarction (NSTEMI), or unstable angina from March 2025 to August 2025. Demographic details, risk factors, treatment modalities, length of hospital stay, and mortality and readmission outcomes were extracted from hospital medical records. Statistical analysis was carried out using SPSS software; descriptive statistics and chi-square tests were applied. Statistical significance was defined as p< 0.05.
Results
The mean age of patients was 58.6 ± 11.4 years, and the majority of the population was male (69.6%). The most frequent presentation was STEMI (53.6%). In-hospital mortality was 10.7% overall and higher among elderly and STEMI patients. Among them, the 30-day readmission rate was 15.2%, mainly because of recurrent chest pain and heart failure. Moreover, the adverse outcomes were significantly associated with comorbidities (for example, hypertension and diabetes).
Conclusion
Despite progress, ACS remains a significant clinical burden, with high mortality and readmission rates in this cohort. It needs to focus mainly on ramping up early intervention measures and monitoring at the time to improve the outcomes once discharged. Larger multicenter studies are needed to confirm our findings and inform regional health planning.
Zitieren
APA
Ravikant, R., Kumar, V., Rani, M., Ranjan, R. K., Kumar, H., & Kumar, R. (2026). A Retrospective Analysis of Outcomes in Patients with Acute Coronary Syndrome, Including Mortality Rates and Readmission Rates. International Journal of Current Pharmaceutical Review and Research, 18(04). https://doi.org/10.25258/ijcpr.18.4.141
Vancouver
Ravikant R, Kumar V, Rani M, Ranjan RK, Kumar H, Kumar R. A Retrospective Analysis of Outcomes in Patients with Acute Coronary Syndrome, Including Mortality Rates and Readmission Rates. International Journal of Current Pharmaceutical Review and Research. 2026;18(04). doi:10.25258/ijcpr.18.4.141
BibTeX
@article{Ravikant2026,
author = {Ravikant, Ravikant and Kumar, Vivek and Rani, Megha and Ranjan, Rajeev Kumar and Kumar, Himanshu and Kumar, Rakesh},
title = {A Retrospective Analysis of Outcomes in Patients with Acute Coronary Syndrome, Including Mortality Rates and Readmission Rates},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {04},
doi = {10.25258/ijcpr.18.4.141}
}
EUVIMED